Publication

Hepatocyte mARC1 promotes fatty liver disease

JHEP Reports 5(5):100693, 2023 Lewis LC, Chen L, Hameed LS, Kitchen RR, Maroteau C, Nagarajan SR, Norlin J, Daly CE, Szczerbinska I, Hjuler ST, Patel R, Livingstone EJ, Durrant TN, Wondimu E, BasuRay S, Chandran A, Lee WH, Hu S, Gilboa B, Grandi ME, Toledo EM, Erikat AHA, Hodson L, Haynes WG, Pursell NP, Coppieters K, Fleckner J, Howson JMM, Andersen B, Ruby MA

Share this page

Resource Library

Related resources
Poster
A3907, a novel inhibitor of bile acid transport in the intestine and the kidney, improves markers of metabolic and hepatic pathology and reduces NAFLD activity score and fibrosis stage in a diet-induced and biopsy-confirmed mouse model of nonalcoholic steatohepatitis
Open
Poster
Obeticholic acid improves histological, biochemical and gene expression profiles in Gubra AMLN mice with diet-induced and biopsy-confirmed NASH
Open
Video
Healthy liver from an adult mouse
Open
Publication
Bariatric surgery in patients with non-alcoholic fatty liver disease – from pathophysiology to clinical effects
Open

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 ­2650

Back To Top